About Mecure Pharma Private Limited
Data last updated:
Mecure Pharma Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24299CH2020PTC043180. Its GSTIN is 04AANCM7286N1ZO (Chandigarh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹50,000. It is led by directors including Nidhi Aggarwal and Ankush Singla.
Its last annual general meeting (AGM) was held on 11 August 2023, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Plot No. 3113 Industrial Area Phase II, Chandigarh, India – 160002.
As per the financials filed for FY 2022, the company reported a revenue of ₹35.47 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹45,515 (net margin -1.3%) and EBITDA of -₹30,659 (EBITDA margin -0.9%).
For more details, the company can be reached via its website mecurepharma.com.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No. 3113 Industrial Area Phase II, Chandigarh, India – 160002
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Mecure Pharma Private Limited
The main business activity of Mecure Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Mecure Pharma Private Limited FY 2022 filings available
Mecure Pharma Private Limited reported revenue of ₹35.47 Lakh (up 1605% YoY) for FY 2022.
Financial Statement Summary of Mecure Pharma Private Limited
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹30,659 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹45,515 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Mecure Pharma Private Limited
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -0.9% | •••• |
| Net Profit Margin | -1.3% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Mecure Pharma are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Mecure Pharma Private Limited
Mecure Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Synartis Pharma Private Limited | ₹35.62 Lakh (FY 2024) | •••• | •••• | 1900.0% | •••• | Hyderabad, Telangana, India |
| Nirman Chemicals Pvt Ltd | ₹35.6 Lakh (FY 2021) | •••• | •••• | 46.0% | •••• | Punjab, India |
| Anuska Agro Tech Private Limited | ₹35.6 Lakh (FY 2025) | •••• | •••• | -40.0% | •••• | Vadodara, Gujarat, India |
| Essell Lubricants and Chemicals Private Limited | ₹35.49 Lakh (FY 2021) | •••• | •••• | 4.0% | •••• | Aurangabad, Bihar, India |
| Bodyblend Wellness Private Limited | ₹35.48 Lakh (FY 2025) | •••• | •••• | 563.0% | •••• | Mumbai, Maharashtra, India |
| Mecure Pharma Private Limited this company | ₹35.47 Lakh (FY 2022) | •••• | •••• | 1605.0% | •••• | Chandigarh, India |
| JD Ceramin Private Limited | ₹35.45 Lakh (FY 2024) | •••• | •••• | -86.0% | •••• | Vadodara, Gujarat, India |
| Tamil Traditional Concept Private Limited | ₹35.44 Lakh (FY 2024) | •••• | •••• | -14.0% | •••• | Chennai, Tamil Nadu, India |
| Crates 24X7 Pharmacy Private Limited | ₹35.41 Lakh (FY 2024) | •••• | •••• | 52.0% | •••• | Lucknow, Uttar Pradesh, India |
| B D Pharmaceuticals Private Limited | ₹35.38 Lakh (FY 2024) | •••• | •••• | -41.0% | •••• | Kolkata, West Bengal, India |
| Paciencia Consumer Goods India Private Limited | ₹35.37 Lakh (FY 2021) | •••• | •••• | 144.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Mecure Pharma by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Mecure Pharma Private Limited
Mecure Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narinder Kumar | Additional Director | 08 Dec 2021 | 4 Years 10 Months | Current |
| Nidhi Aggarwal | Director | 25 Aug 2020 | 6 Years 1 Months | Current |
| Ankush Singla | Director | 25 Aug 2020 | 6 Years 1 Months | Current |
Charges & Borrowings of Mecure Pharma Private Limited
Mecure Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Mecure Pharma Private Limited
Employment history and EPFO contributions of people linked to Mecure Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Mecure Pharma Private Limited
Mecure Pharma Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Narinder Kumar was appointed as Additional Director on 08 Dec 2021.
Credit Ratings, Litigation & Regulatory Alerts for Mecure Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Mecure Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mecure Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Mecure Pharma Private Limited
Mecure Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AANCM7286N1ZO | Chandigarh | Active | 08 Nov 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mecure Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mecure Pharma Private Limited
Mecure Pharma is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 August 2020 (6+ years old) and is registered under CIN U24299CH2020PTC043180.
Mecure Pharma reported revenue of ₹35.47 Lakh for FY 2022 (up 1605% YoY).
Mecure Pharma has 3 current directors:
- Narinder Kumar - Additional Director
- Nidhi Aggarwal - Director
- Ankush Singla - Director
Mecure Pharma reported a net loss of ₹45,515 (net margin -1.3%) and EBITDA of -₹30,659 (EBITDA margin -0.9%) for FY 2022, as per its filed financial statements.
The GSTIN of Mecure Pharma is 04AANCM7286N1ZO, registered in Chandigarh.
The CIN (Corporate Identification Number) of Mecure Pharma is U24299CH2020PTC043180. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mecure Pharma was incorporated on 25 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Mecure Pharma by revenue are Synartis Pharma Private Limited, Nirman Chemicals Pvt Ltd, Anuska Agro Tech Private Limited, Essell Lubricants and Chemicals Private Limited, Bodyblend Wellness Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Narinder Kumar was appointed as Additional Director on 08 Dec 2021. Ankush Singla was appointed as Director on 25 Aug 2020. Nidhi Aggarwal was appointed as Director on 25 Aug 2020.
Mecure Pharma can be reached through the website mecurepharma.com. Its registered office is in Chandigarh, India.
The registered office of Mecure Pharma is at Plot No. 3113 Industrial Area Phase II, Chandigarh, India – 160002.